Making the move to value-based health
IBM Healthcare & Life Sciences Industries Blog
by Heather Fraser
4y ago
A few years ago, the IBV Institute for Business Value published a report which predicted the convergence of population health management and precision medicine into a new healthcare model we called Precision Health and Wellness. We believed a key component of that model would be a continued transition to outcome-based results and lower costs. Fast forward to 2019 and our latest research found that not only had those predictions become real but that the speed of change had increased. Globally, healthcare systems are looking at how to maintain access, quality, and efficiency. Emphasis has shifte ..read more
Visit website
Digital therapeutics: Paving the way for value
IBM Healthcare & Life Sciences Industries Blog
by Sunanda Saxena
4y ago
Digital Therapeutics (DTx) interventions are gathering momentum and are increasingly being integrated into clinical practice for a wide range of conditions ranging from asthma, substance abuse, mental health to cancer. The total DTx market in the US is expected to grow to $4.42 Billion by 2023 [i]  and while it is still a fraction of the total healthcare spend, this emerging digital health sector is paving the way for new business models. What is DTx? While the DTx story is already on its way to primetime, there is still fog around a common lexicon to understand and critique DTx; it is commonl ..read more
Visit website
The Enormous Potential of AI for Pharmaceutical
IBM Healthcare & Life Sciences Industries Blog
by Edward ffrench
4y ago
The adoption of Artificial Intelligence (AI) in research-intensive organizations has essentially seen linear growth in recent years. Pharmaceutical, CRO, university and healthcare organizations are beginning to shift away from theoretical plans to genuine practical applications of machine intelligence. But what problems are these institutions trying to solve? Dr. Lester Russell, Associate Partner, Clinical Digital Innovation at IBM and a part-time General Practitioner (GP) in the South of England, provides his perspective on the use of Artificial Intelligence within the life sciences industrie ..read more
Visit website
The future of disease management – the opportunities and challenges of digital interventions
IBM Healthcare & Life Sciences Industries Blog
by Alexander Buesser
5y ago
Today’s industries are being disrupted by software-driven innovations, as evidenced by Amazon’s impact in retail markets, Netflix’s success over traditional cable providers, and the upheaval in hospitality industry from online marketplaces such as Airbnb. It is hence no surprise that the healthcare industry is seeing a surge in the development of software driven products to drive new healthcare services or augment and complement existing ones. One of the most notable trends is the area of digital therapeutics, otherwise known as “DTx”.  Digital therapeutics, as defined by the Digital Therapeut ..read more
Visit website
Advance precision medicine with trusted data and AI solutions
IBM Healthcare & Life Sciences Industries Blog
by Kimberly Smith
5y ago
Advancing precision medicine to improve diagnoses and treatments relies largely on big data coming from many sources and instruments in volumes that we have never seen before. This exploding growth of data, represented by very large files and many complex data types, pose enormous challenges for researchers that are trying to make sense of all this data to better understand the human genome and discover the biological or environmental factors that are causing disease. In an increasingly competitive market where time-to-market is so critical, life sciences institutes must reimagine their approa ..read more
Visit website

Follow IBM Healthcare & Life Sciences Industries Blog on FeedSpot

Continue with Google
Continue with Apple
OR